Publication

Publication:
Phase IIB efficacy trial of mosaic HIV-1 vaccine regime in African women: IMBOKODO

Gray, G.E
; 
Mngadi, K
; 
Lavreys, L
; 
Luedtke, A
; 
Nijs, S
; 
Stieh, D
; 
Juraska, M
; 
Hyrien, O
; 
Swann, E
; 
Tomaras, G
... show 4 more
Citations
Altmetric:
Abstract
Imbokodo is the first trial evaluating clinical efficacy of a heterologous HIV-1 vaccine regimen consisting of an Ad26 vector (Ad26.Mos4.HIV) expressing mosaic.
Description
Conference on Retroviruses and Opportunistic Infections (CROI) 12-16 Feburary 2022.
Date
2022-02-16
Journal Title
Journal ISSN
Volume Title
Publisher
Conference on Retroviruses and Opportunistic Infections
Collections
Corporate Division: Conference Papers, Presentations and Posters
Show all metadata
Files
Name: Gray G_2022_Phase IIB efficacy.mp3
Size: 3.68 MB
Kind: mp3
Research Projects
Organizational Units
Journal Issue
Keywords
HIV-1,Vaccine,African Women,HIV prevention
Citation
URI
https://www.croiwebcasts.org/p/2022croi/croi/121
 https://hdl.handle.net/11288/597787
Embedded videos